Market Access The new commercialisation playbook: What BIO 2026 taught eme... BIO International focused on how emerging biotech companies should approach their first product launch outside the United States, typically in Europe.
News MFN affecting Swiss medicines access, says Interpharma Pharma groups have held back from submitting around a third of their new medicines for reimbursement in Switzerland, impeding patient access.
News AbbVie makes record investment in North Carolina plant AbbVie's $100bn programme of facility investments in the US has continued with a new 185-acre campus in Durham, North Carolina.
Market Access Highlights from the UK’s December 2025 VPAG metrics Leela Barham looked at the latest metrics used to monitor the UK’s voluntary pricing scheme.
News J&J scores EU approval for Tecvayli combo in second line Johnson & Johnson's multiple myeloma regimen is now approved as a second line treatment in both the US and the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.